Andra AP-fonden’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Sell
253,329
-10,400
-4% -$996K 0.26% 77
2025
Q4
$25.3M Sell
263,729
-57,400
-18% -$5.58M 0.31% 92
2025
Q3
$30.6M Buy
321,129
+258,500
+413% +$23.8M 0.39% 83
2025
Q2
$5.46M Buy
62,629
+30,400
+94% +$2.58M 0.08% 269
2025
Q1
$2.9M Sell
32,229
-14,700
-31% -$1.32M 0.05% 326
2024
Q4
$3.75M Buy
46,929
+28,400
+153% +$2.46M 0.06% 312
2024
Q3
$1.67M Buy
+18,529
New +$1.56M 0.02% 363
2024
Q1
Sell
-40,429
Closed -$3.33M 408
2023
Q4
$3.33M Sell
40,429
-1,200
-3% -$91.5K 0.18% 198
2023
Q3
$3.26M Sell
41,629
-3,600
-8% -$301K 0.19% 213
2023
Q2
$3.98M Sell
45,229
-20,800
-32% -$1.79M 0.1% 442
2023
Q1
$5.32M Sell
66,029
-13,871
-17% -$1.13M 0.14% 333
2022
Q4
$6.21M Buy
79,900
+22,100
+38% +$1.79M 0.19% 239
2022
Q3
$4.67M Buy
57,800
+9,200
+19% +$827K 0.15% 304
2022
Q2
$4.36M Buy
+48,600
New +$4.92M 0.12% 369
2021
Q4
$7.31M Sell
70,700
-6,500
-8% -$753K 0.15% 325
2021
Q3
$9.68M Buy
77,200
+200
+0.3% +$25.9K 0.2% 209
2021
Q2
$9.56M Sell
77,000
-9,100
-11% -$1.14M 0.2% 218
2021
Q1
$10.2M Buy
86,100
+2,100
+3% +$246K 0.22% 161
2020
Q4
$9.84M Buy
84,000
+31,500
+60% +$3.47M 0.22% 156
2020
Q3
$5.46M Sell
52,500
-10,700
-17% -$1.07M 0.15% 335
2020
Q2
$5.79M Buy
63,200
+3,200
+5% +$307K 0.17% 263
2020
Q1
$5.41M Sell
60,000
-4,100
-6% -$436K 0.2% 138
2019
Q4
$7.27M Sell
64,100
-16,000
-20% -$1.76M 0.21% 115
2019
Q3
$8.7M Buy
80,100
+1,300
+2% +$136K 0.26% 24
2019
Q2
$7.67M Sell
78,800
-17,300
-18% -$1.58M 0.22% 86
2019
Q1
$8.75M Buy
+96,100
New +$8.6M 0.25% 45
2018
Q3
$9.82M Buy
99,800
+21,000
+27% +$1.94M 0.25% 61
2018
Q2
$6.75M Buy
78,800
+2,800
+4% +$234K 0.18% 216
2018
Q1
$6.1M Sell
76,000
-89,365
-54% -$7.37M 0.16% 303
2017
Q4
$13.4M Buy
165,365
+10,065
+6% +$806K 0.3% 85
2017
Q3
$12.1M Buy
155,300
+6,400
+4% +$531K 0.28% 97
2017
Q2
$13.2M Sell
148,900
-5,000
-3% -$422K 0.33% 79
2017
Q1
$12.4M Sell
153,900
-16,400
-10% -$1.28M 0.29% 81
2016
Q4
$12.1M Buy
+170,300
New +$13.4M 0.33% 75
2016
Q3
Sell
-79,600
Closed -$6.91M 629
2016
Q2
$6.91M Sell
79,600
-3,400
-4% -$275K 0.18% 149
2016
Q1
$6.22M Buy
83,000
+3,200
+4% +$241K 0.16% 157
2015
Q4
$6.14M Sell
79,800
-6,600
-8% -$497K 0.18% 147
2015
Q3
$5.78M Sell
86,400
-5,400
-6% -$398K 0.17% 154
2015
Q2
$6.8M Sell
91,800
-45,282
-33% -$3.46M 0.2% 148
2015
Q1
$10.7M Buy
137,082
+37,382
+37% +$2.83M 0.3% 81
2014
Q4
$7.2M Sell
99,700
-67,800
-40% -$4.71M 0.17% 189
2014
Q3
$10.4M Sell
167,500
-49,000
-23% -$3.12M 0.24% 123
2014
Q2
$13.8M Sell
216,500
-43,900
-17% -$2.67M 0.3% 87
2014
Q1
$16M Sell
260,400
-57,200
-18% -$3.33M 0.37% 58
2013
Q4
$18.2M Buy
317,600
+37,200
+13% +$2.11M 0.43% 45
2013
Q3
$14.9M Buy
280,400
+52,400
+23% +$2.82M 0.38% 53
2013
Q2
$11.7M Buy
+228,000
New +$11.3M 0.31% 76

Other funds holding MDT

Andra AP-fonden's MDT Position: Q1 2026 in Review

Andra AP-fonden reduced its Medtronic (MDT) stake by 3.9% in Q1 2026, selling an estimated $996K and leaving 253,329 shares worth $22M. The position accounts for 0.26% of the portfolio, ranked #77.

Andra AP-fonden first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $30.6M in Q3 2025. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Andra AP-fonden held 253,329 shares of Medtronic worth $22M as of Q1 2026.
  • Andra AP-fonden sold 10,400 Medtronic shares in Q1 2026, an estimated $996K.
  • Medtronic made up 0.26% of Andra AP-fonden's portfolio in Q1 2026, its #77 holding.
  • Andra AP-fonden first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
  • Andra AP-fonden's Medtronic position peaked at $30.6M in Q3 2025.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.